Top compounds associated with response to DCC


Feature Type Standardized
Nominal ANOVA
mRNA Bosutinib CTRPv2 pan-cancer AAC -0.0032 0.9
mRNA Crizotinib CTRPv2 pan-cancer AAC 0.0029 0.9
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.0034 0.9
mRNA tivozanib GDSC1000 pan-cancer AAC -0.0032 0.9
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.0027 0.9
mRNA valdecoxib CTRPv2 pan-cancer AAC 0.0027 0.9
mRNA BIBW2992 CTRPv2 pan-cancer AAC 0.0026 0.9
mRNA Cytarabine FIMM pan-cancer AAC 0.011 0.9
mRNA Midostaurin GDSC1000 pan-cancer AAC -0.0025 0.9
mRNA lenalidomide FIMM pan-cancer AAC 0.012 0.9
Download CSV